These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 458631)

  • 41. Assay-dependent kinetics of heparin: evidence for rapid in vivo activation of heparin.
    McGowan FX; Nash PV; Bjornsson TD
    Br J Clin Pharmacol; 1983 Dec; 16(6):677-82. PubMed ID: 6661353
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A dosing nomogram for continuous infusion intravenous naloxone.
    Goldfrank L; Weisman RS; Errick JK; Lo MW
    Ann Emerg Med; 1986 May; 15(5):566-70. PubMed ID: 3963538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of heparin administration.
    Perry MO; Horton J
    Arch Surg; 1976 Apr; 111(4):403-9. PubMed ID: 1259578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic evidence for possible renal accumulation of model organic anions in rats.
    Nagwekar JB; Cheon JW
    J Pharm Sci; 1981 Mar; 70(3):295-8. PubMed ID: 7264895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dextrose and sorbitol as diluents for continuous intravenous heparin infusion.
    Chessells JM; Braithwaite TA; Chamberlain DA
    Br Med J; 1972 Apr; 2(5805):81-2. PubMed ID: 5018311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparin therapy adjusted for body weight.
    Talstad I
    Am J Clin Pathol; 1985 Mar; 83(3):378-81. PubMed ID: 3976573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.
    Mallo C; Zaĭdan R; Galy G; Vermeulen E; Brun J; Chazot G; Claustrat B
    Eur J Clin Pharmacol; 1990; 38(3):297-301. PubMed ID: 2340850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin kinetics determined by three assay methods.
    Bjornsson TD; Wolfram KM; Kitchell BB
    Clin Pharmacol Ther; 1982 Jan; 31(1):104-13. PubMed ID: 7053298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparin pharmacokinetics: increased requirements in pulmonary embolism.
    Simon TL; Hyers TM; Gaston JP; Harker LA
    Br J Haematol; 1978 May; 39(1):111-20. PubMed ID: 666973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration.
    Bara L; Billaud E; Gramond G; Kher A; Samama M
    Thromb Res; 1985 Sep; 39(5):631-6. PubMed ID: 4082105
    [No Abstract]   [Full Text] [Related]  

  • 51. The biologic half-life of heparin.
    McAvoy TJ
    Clin Pharmacol Ther; 1979 Mar; 25(3):372-9. PubMed ID: 761447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Volume of distribution and half-life of heparin after intravenous administration].
    Zöllner N; Kaiser W
    Res Exp Med (Berl); 1972; 158(2):89-94. PubMed ID: 4561302
    [No Abstract]   [Full Text] [Related]  

  • 53. The observation of heparin on endothelium after injection.
    Hiebert LM; Jaques LB
    Thromb Res; 1976 Feb; 8(2):195-204. PubMed ID: 1251350
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of heparin on bilirubin clearance in rats: pharmacokinetic consequences of extensive hepatic extraction of plasma protein binding inhibitors.
    Wiegand UW; Soda DM; Levy G
    J Pharm Sci; 1980 Oct; 69(10):1228-30. PubMed ID: 7420299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue distribution and myelotoxicity of daunomycin in the rat: rapid bolus injection vs continuous infusion.
    Nooter K; Sonneveld P; Martens A; Hagenbeek A; Schultz F
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):801-6. PubMed ID: 3770038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hexobarbitone disposition at different stages of intensive care treatment.
    Rietbrock I; Lazarus G; Richter E; Breimer DD
    Br J Anaesth; 1981 Mar; 53(3):283-93. PubMed ID: 7470363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics in clinical practice. 2. Applications.
    Gibaldi M; Levy G
    JAMA; 1976 May; 235(18):1987-92. PubMed ID: 946509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The biodistribution of exogenous [35S]heparin in the dog.
    Schaefer C; Lo Bue J; Gollub S
    Proc Soc Exp Biol Med; 1980 May; 164(1):69-74. PubMed ID: 7375475
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.
    Koup JR; Greenblatt DJ; Jusko WJ; Smith TW; Koch-Weser J
    J Pharmacokinet Biopharm; 1975 Jun; 3(3):181-92. PubMed ID: 1159622
    [No Abstract]   [Full Text] [Related]  

  • 60. Heparin kinetics: variables related to disposition and dosage.
    Cipolle RJ; Seifert RD; Neilan BA; Zaske DE; Haus E
    Clin Pharmacol Ther; 1981 Mar; 29(3):387-93. PubMed ID: 7471609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.